LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

Home・Aktien・Schrodinger Inc

Schrodinger Inc

Open

BrancheGesundheitswesen

13.31 0.76

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

13.22

Max

13.39

Schlüsselkennzahlen
By Trading Economics
Einkommen	-196M -60M
Verkäufe	-29M 59M
EPS	-0.621
Gewinnspanne	-102.456
Angestellte	850
EBITDA	-85M -49M

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+41.35% upside

Dividenden
By Dow Jones
Nächstes Ergebnis	5. Aug. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-64M 900M
Vorheriger Eröffnungskurs	12.55
Vorheriger Schlusskurs	13.31

Nachrichtenstimmung

By Acuity

100%

326 / 345 Ranking in Healthcare

Schrodinger Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

24. Mai 2026, 23:46 UTC

Market Talk

Pullback in Oil Prices Could Temper Inflation Expectations -- Market Talk

24. Mai 2026, 23:45 UTC

Market Talk

Gold, Silver Rise on Hopes for U.S.-Iran Deal -- Market Talk

24. Mai 2026, 23:42 UTC

Market Talk

Mineral Resources Bull More Positive Post Site Visit -- Market Talk

24. Mai 2026, 23:34 UTC

Market Talk

Oil Falls Amid Prospects for Reopening of Strait of Hormuz -- Market Talk

24. Mai 2026, 23:11 UTC

Market Talk

RBNZ Likely to Stand Pat But Watch for Dissent -- Market Talk

24. Mai 2026, 22:26 UTC

Akquisitionen, Fusionen, Übernahmen

Beach Energy: La Bella 2 Will No Longer Be Drilled as Part of Equinox Campaign

24. Mai 2026, 22:25 UTC

Akquisitionen, Fusionen, Übernahmen

Beach Energy: Implied Transaction Value of Around A$130 Million After Tax

24. Mai 2026, 22:25 UTC

Akquisitionen, Fusionen, Übernahmen

Beach Energy: Royalty Payments Likely to Total Around A$140 Million Based on Resource Booking

24. Mai 2026, 22:24 UTC

Akquisitionen, Fusionen, Übernahmen

Beach Energy to Get Production Royalty of A$3.75/GJ in Deal

24. Mai 2026, 22:24 UTC

Akquisitionen, Fusionen, Übernahmen

Beach Energy to Get A$70 Million Cash Proceeds When Deal Completes

24. Mai 2026, 22:23 UTC

Akquisitionen, Fusionen, Übernahmen

Beach Energy Says Deal Includes Artisan Natural-Gas Discovery

24. Mai 2026, 22:23 UTC

Akquisitionen, Fusionen, Übernahmen

Beach Energy Sells 60% Operated Interest in VIC/L35 Block in Otway Basin

24. Mai 2026, 22:11 UTC

Market Talk

Oil Price Unlikely to Return to Pre-Conflict Levels This Year -- Market Talk

24. Mai 2026, 22:04 UTC

Market Talk

Oil Price Likely Lower, Equities Higher on Iran Deal Talks Progress -- Market Talk

23. Mai 2026, 08:20 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Financial Services Roundup: Market Talk

23. Mai 2026, 08:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

22. Mai 2026, 21:10 UTC

Ergebnisse

These Stocks Are Today's Movers: Dell, Apple, IBM, Estée Lauder, Futu, Rocket Lab, Workday, and More -- Barrons.com

22. Mai 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

22. Mai 2026, 20:50 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Financial Services Roundup: Market Talk

22. Mai 2026, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

22. Mai 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

22. Mai 2026, 19:47 UTC

Ergebnisse

Nvidia Has a Plan to Get the Stock Moving Again -- Barrons.com

22. Mai 2026, 19:17 UTC

Market Talk

U.S. Natural Gas Retreats As Weather Outlook Cools -- Market Talk

22. Mai 2026, 19:10 UTC

Market Talk

Oil Futures Edge Up Ahead of U.S. Long Weekend -- Market Talk

22. Mai 2026, 18:54 UTC

Market Talk

Global Equities Roundup: Market Talk

22. Mai 2026, 18:54 UTC

Market Talk

Kroger Seen Narrowing Pricing Gap Versus Walmart -- Market Talk

22. Mai 2026, 18:38 UTC

Market Talk

Canada's Population Slowdown Hits Demand for Consumer Companies -- Market Talk

22. Mai 2026, 18:35 UTC

Akquisitionen, Fusionen, Übernahmen

IMAX Might Be Exploring a Sale. Who Could Be Buying. -- Barrons.com

22. Mai 2026, 18:09 UTC

Market Talk

Centralized Crypto Lending Slows in 1Q -- Market Talk

22. Mai 2026, 17:58 UTC

Market Talk

U.S. Oil Rig Count Shows Signs of Picking Up -- Market Talk

Peer-Vergleich

Kursveränderung

Schrodinger Inc Prognose

Kursziel

By TipRanks

41.35% Vorteil

12-Monats-Prognose

Durchschnitt 18.8 USD 41.35%

Hoch 24 USD

Tief 13 USD

Basierend auf 7 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Schrodinger Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

7 ratings

Buy

Halten

Sell

Basierend auf 7 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Schrodinger Inc – Dist abgegeben haben.

Stimmung

By Acuity

326 / 345 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Schrodinger Inc

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. It has a research collaboration and license agreement with Novartis AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.